Search
C4 Therapeutics Inc
CCCCAdd to Watchlist
3.100USD
+0.150+5.08%
Close 11-06 16:00（ET）
381.39MMarket Cap
LossP/E TTM
After-hours 16:12 (ET)3.060USD-0.025-0.81%
After-hours 16:12 (ET)Today
+5.08%
5 Days
-8.01%
1 Month
+7.64%
6 Months
+5.80%
Year to Date
+62.30%
1 Year
+30.25%
Key Figures
2.960Open
3.210High
573.82KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.47%Turnover Ratio
2.950Prev. Close
2.951Low
1.78MTurnover
LossP/E Static
1.67P/B
0.00%Div Yield TTM
-32.02%ROA
5.17052wk High
0.23Volume Ratio
-105.32MNet Profit
123.03MShares
-1.0943EPS TTM
2.84Beta
-48.35%ROE
1.69052wk Low
10.68%Amplitude
100.00%Gross Margin
381.39MMarket Cap
3.23Reward/Risk
5.10%Risk Rate
More news coming soon, stay tuned...
C4 Therapeutics Inc's Score
-0.01vs previous score
Forecast8.57
Financial Health7.31
Technical4.96
Valuation Dimensions6.73
Institutional Confidence5.00
Risk Assessment5.18
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
C4 Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.16/-0.20
Revenue / Forecast
8.47M/8.51M
C4 Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCCCC
Number of employees110
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Point72 Asset Management, L.P. | 8.54% |
| Morgan Stanley & Co. LLC | 8.10% |
| RA Capital Management, LP | 7.24% |
| Lynx1 Capital Advisors LLC | 6.33% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 24.05% |
| Hedge Fund | 20.77% |
| Research Firm | 12.49% |
| Venture Capital | 7.36% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of C4 Therapeutics Inc (CCCC)?
The current price of C4 Therapeutics Inc (CCCC) is 3.10.
What is the symbol of C4 Therapeutics Inc?
The ticker symbol of C4 Therapeutics Inc is CCCC.
What is the 52-week high of C4 Therapeutics Inc?
The 52-week high of C4 Therapeutics Inc is 5.17.
What is the 52-week low of C4 Therapeutics Inc?
The 52-week low of C4 Therapeutics Inc is 1.69.
What is the market capitalization of C4 Therapeutics Inc?
The market capitalization of C4 Therapeutics Inc is 381.39M.
Is C4 Therapeutics Inc (CCCC) currently rated as Buy, Hold, or Sell?
According to analysts, C4 Therapeutics Inc (CCCC) has an overall rating of Buy, with a price target of 12.62.
What is the Earnings Per Share (EPS TTM) of C4 Therapeutics Inc (CCCC)?
The Earnings Per Share (EPS TTM) of C4 Therapeutics Inc (CCCC) is -1.09.